×
About 1,187 results

ALLMedicine™ Adult-onset Still's Disease Center

Research & Reviews  585 results

The Association of Serum IL-10 Levels with the Disease Activity in Systemic-Onset Juven...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007368
Mediators of Inflammation; Peng Y, Liu X et. al.

Apr 7th, 2021 - Interleukin-10 (IL-10) has been suggested as a biomarker of disease activity in patients with adult-onset Still's disease (AOSD). In this study, we evaluated the serum IL-10 levels and investigated its clinical relevance in systemic-onset juvenile...

Total metabolic lesion volume of lymph nodes measured by 18F-FDG PET/CT: a new predicto...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008587
Arthritis Research & Therapy; Wan L, Gao Y et. al.

Mar 31st, 2021 - To investigate the potential utility of quantitative parameters obtained by 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in the assessment of disease severity and the occurrence of macrophage activation ...

18F-FDG PET-CT in adult-onset Still's disease.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009220
BMJ Case Reports; Shimizu H, Nishioka H

Mar 30th, 2021 - 18F-FDG PET-CT in adult-onset Still's disease.|2021|Shimizu H,Nishioka H,|

see more →

Clinicaltrials.gov  595 results

The Association of Serum IL-10 Levels with the Disease Activity in Systemic-Onset Juven...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007368
Mediators of Inflammation; Peng Y, Liu X et. al.

Apr 7th, 2021 - Interleukin-10 (IL-10) has been suggested as a biomarker of disease activity in patients with adult-onset Still's disease (AOSD). In this study, we evaluated the serum IL-10 levels and investigated its clinical relevance in systemic-onset juvenile...

Total metabolic lesion volume of lymph nodes measured by 18F-FDG PET/CT: a new predicto...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008587
Arthritis Research & Therapy; Wan L, Gao Y et. al.

Mar 31st, 2021 - To investigate the potential utility of quantitative parameters obtained by 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in the assessment of disease severity and the occurrence of macrophage activation ...

18F-FDG PET-CT in adult-onset Still's disease.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009220
BMJ Case Reports; Shimizu H, Nishioka H

Mar 30th, 2021 - 18F-FDG PET-CT in adult-onset Still's disease.|2021|Shimizu H,Nishioka H,|

see more →

News  7 results

FDA Approves Canakinumab (Ilaris), First Drug for Adult-Onset Still's Disease
https://www.medscape.com/viewarticle/932625

Jun 18th, 2020 - The Food and Drug Administration has expanded the indications for canakinumab (Ilaris) to include all patients with active Still's disease older than 2 years, adding adult-onset Still's disease (AOSD) to a previous approval for juvenile-onset Stil...

IL-6 for Adult Still's: A New Option?
https://www.medpagetoday.com/rheumatology/generalrheumatology/75699

Oct 14th, 2018 - Action Points Some clinical benefits were seen among patients with adult-onset Still's disease treated with tocilizumab (Actemra) in a small clinical trial, but the study's primary endpoint was not met. During the double-blind part of the trial, t...

Blocking IL-18 Shows Promise in Still's Disease
https://www.medpagetoday.com/rheumatology/arthritis/71381

Feb 26th, 2018 - Action Points Tadekinig alfa, a recombinant human IL-18 binding protein, showed promise as a novel strategy for the treatment of refractory adult-onset Still's disease (AOSD), in a phase II, European, multicenter study of 23 patients. Note that AO...

Actemra Aids in Adult Still's
https://www.medpagetoday.com/rheumatology/arthritis/44319

Feb 14th, 2014 - Action Points Patients with refractory adult-onset Still's disease had improvements in both systemic and joint symptoms when treated with tocilizumab (Actemra), a monoclonal antibody against the IL 6 receptor. Note that patients continued to be fo...

Steroids and DMARDs Needed in Adult-Onset Still's
https://www.medpagetoday.com/rheumatology/arthritis/21574

Aug 7th, 2010 - Action Points Explain to interested patients that in this study of patients with adult-onset Still's disease (aka systemic juvenile idiopathic arthritis), treatment with NSAIDs alone was usually not effective whereas steroids usually were. Note th...

see more →